Last reviewed · How we verify
NCT07317297
Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease
NA trial testing Extracorporeal Shockwave Therapy in Peyronie Disease in 50 participants. Currently enrolling.
15 February 2026
Quick facts
| Lead sponsor | Uskudar University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 10 January 2026 |
| Primary completion | 15 February 2026 |
| Estimated completion | 30 March 2026 |
| Sites | 1 location across Azerbaijan |
Drugs / interventions tested
- Extracorporeal Shockwave Therapy
- control
Conditions studied
- Peyronie Disease — all drugs for Peyronie Disease →
Sponsor
Uskudar University
Who can join
Adults 18 to 65, male only, with Peyronie Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Investigation of the effectiveness of extracorporeal shock wave therapy in the treatment of Peyronie's disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07317297
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Extracorporeal Shockwave Therapy
Trials testing the same drug.
- NCT07483320 — Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy · NA · not yet recruiting
- NCT07196267 — Shockwave and Cryoflow for Shoulder Pain After Stroke · NA · completed
- NCT06210399 — Shockwave Therapy in Patients With Chronic Wounds · NA · completed
- NCT06548321 — Benefits of Extracorporeal Shockwave Therapy to Reduce Spasticity in Stroke/CP · NA · active not recruiting
- NCT06898125 — Evaluation of Extracorporeal Shockwave Therapy and Complex Decongestive Therapy Results in Patients With Lipedema · NA · completed
Other recruiting trials for Peyronie Disease
Currently open trials in the same condition.
- NCT07010900 — Platelet-Rich Plasma Injections From Cord Blood + Penile Traction vs. Penile Traction Alone in Patients With Peyronie's · NA · recruiting
- NCT05777031 — Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease · Phase 4 · recruiting
- NCT07341529 — Pilot Study on the Efficacy and Safety of FIBRORESTIL® as an Adjuvant Intralesional Treatment in Patients With Peyronie' · NA · active not recruiting
Other Uskudar University trials
Trials by the same sponsor.
- NCT07447193 — Investigation of Pain Perception According to Gender in Individuals With Scoliosis · NA · recruiting
- NCT07498088 — THE EFFECT OF HAPTONOMY PRACTICE ON PREGNANT WOMEN WITH A HISTORY OF ABORTION. · NA · not yet recruiting
- NCT07447180 — The Effectiveness of Exercise Combined With Ergonomics Training for Musculoskeletal Pain Seen in Pastry Chefs · NA · recruiting
- NCT07448467 — Investigation of the Effectiveness of Progressive Resistance Exercise Training in the Management of Lymphedema. · NA · recruiting
- NCT07498114 — Association Between Fatigue Severity and Health-Related Quality of Life in Individuals With Stroke · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07317297 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uskudar University
- Last refreshed: 16 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07317297.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing